Cargando…
Effects of Intravenous Glucose Load on Insulin Secretion in Patients With Ketosis-Prone Diabetes During Near-Normoglycemia Remission
OBJECTIVE: Most patients with ketosis-prone type 2 diabetes (KPD) discontinue insulin therapy and remain in near-normoglycemic remission. The aim of this study was to determine the effect of glucotoxicity on β-cell function during remission in obese patients with KPD. RESEARCH DESIGN AND METHODS: Ag...
Autores principales: | Gosmanov, Aidar R., Smiley, Dawn, Robalino, Gonzalo, Siqueira, Joselita M., Peng, Limin, Kitabchi, Abbas E., Umpierrez, Guillermo E. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
American Diabetes Association
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2845041/ https://www.ncbi.nlm.nih.gov/pubmed/20067967 http://dx.doi.org/10.2337/dc09-1687 |
Ejemplares similares
-
Lack of Lipotoxicity Effect on β-Cell Dysfunction in Ketosis-Prone Type 2 Diabetes
por: Umpierrez, Guillermo E., et al.
Publicado: (2010) -
RF28 | PSUN184 New American Diabetes Association Definition of Diabetes Remission Does not Correlate with Time in Remission in Ketosis-Prone Diabetes
por: Oladejo, Omolade, et al.
Publicado: (2022) -
Multitissue Insulin Resistance Despite Near-Normoglycemic Remission in Africans With Ketosis-Prone Diabetes
por: Choukem, Simeon-Pierre, et al.
Publicado: (2008) -
β- and α-Cell Dysfunctions in Africans With Ketosis-Prone Atypical Diabetes During Near-Normoglycemic Remission
por: Choukem, Siméon-Pierre, et al.
Publicado: (2013) -
Clinical and Biochemical Characteristics and Treatment Outcomes of Ketosis-Prone Diabetes: The Remission Prone Diabetes
por: Waddankeri, Swaraj Shrikant, et al.
Publicado: (2021)